Duane Nash, Director at Akebia Therapeutics, Inc. (AKBA), sold 11,933 shares at $11.19 ($134K) on 2014-12-26, disclosed to the SEC on 2014-12-29.
Scheduled sale ($134k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.26 | 6,764 | $76K | 56.8% |
| 2 | $11.19 | 5,169 | $58K | 43.2% |
| Total | $11.23 avg | 11,933 | $134K | 100% |
| Filing → |
| IMUX | BUY | 2021-08-11 | $10K | — | Filing → |
| IMUX | BUY | 2021-05-12 | $51K | — | Filing → |
| IMUX | SELL | 2019-12-04 | $31K | — | Filing → |